Drowsiness News and Research

RSS

Snooze alarms steal hours of sleep each month, new research shows

Researchers analyzed over 3 million sleep sessions from a global cohort of smartphone users and found that more than half used snooze alarms, with frequent snoozing linked to irregular sleep patterns. The study highlights potential health implications and the need for further research into the effects of repeated snooze use.

20 May 2025

Ubrogepant relieves early migraine symptoms and may help prevent full-blown attacks

A phase 3 trial found that ubrogepant, given during the premonitory phase of migraine, improved common warning symptoms such as fatigue, light and sound sensitivity, and neck pain. These benefits were observed as early as one hour post-treatment, suggesting early intervention can reduce migraine burden.

15 May 2025

Ten-year data confirm exercise is a powerful tool against depression

Researchers review how exercise influences depression in otherwise healthy adults.

7 May 2025

How to manage allergies in children

When a child's sniffles and sneezing won't go away for weeks, the cause might be allergies.

13 Mar 2025

Glycerol in slush ice drinks can make children sick

Slush ice drinks made with glycerol have been found to make children sick. Doctors and medical scientists in Ireland and the UK investigated following reported sickness connected with the icy refreshments.

12 Mar 2025

Morning coffee cuts health risks, but all-day sipping doesn’t

Moderate morning coffee consumption may lower all-cause and cardiovascular mortality risks, but coffee consumed throughout the day offers no similar benefits.

13 Jan 2025

New oral peptide therapy offers hope for chronic abdominal pain

A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain.

22 Nov 2024

Exploring the role of suvorexant in reducing delirium among older adults

Delirium is a sudden onset and temporary state of disturbed consciousness or cognition, occurring due to underlying medical issues like fever or alcohol withdrawal.

29 Aug 2024

FDA-approved Alzheimer's drug induces torpor-like state in tadpoles

27 Aug 2024

FDA-approved drug could revolutionize organ transplantation

Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University report that they were able to successfully put tadpoles of Xenopus laevis frogs into a hibernation-like torpor state using donepezil (DNP), a drug approved by the FDA to treat Alzheimer's. The team had previously used another drug, SNC80, to achieve similar results in tadpoles and enhance the survival of whole mammalian hearts for transplants, but SNC80 is not approved for clinical use in humans because it can cause seizures. By contrast, DNP is already being used in the clinic, meaning it potentially could be rapidly repurposed for use in emergency situations to prevent irreversible organ injury while a person is being transported to a hospital.

23 Aug 2024

Dopaminergic drug levodopa linked to better sleep in Parkinson’s patients

A study involving 22 Parkinson's disease (PD) patients has shown that use of the dopaminergic drug levodopa improves sleep quality.

13 Aug 2024

New ear EEG earbuds monitor brain waves to combat workplace drowsiness

Everyone gets sleepy at work from time to time, especially after a big lunch. But for people whose jobs involve driving or working with heavy machinery, drowsiness can be extremely dangerous - if not outright deadly.

7 Aug 2024

Cannabigerol shows promise in reducing anxiety and stress, study finds

Whether the phytocannabinoid cannabigerol impacted mood, stress, and anxiety and caused any related adverse effects of cognitive or motor impairment.

5 Aug 2024

Light-activated drugs: A revolutionary approach in neuropathic pain treatment

Light can be used to activate drugs in specific parts of the body through photopharmacology.

11 Jul 2024

Studies underscore the relationship between narcolepsy and cardiovascular disease

Two new studies to be presented at the SLEEP 2024 annual meeting show that narcolepsy is an independent risk factor for cardiovascular disease and adverse cardiac events.

4 Jun 2024

Sleep strategies may boost ultramarathon performance, study finds

Study investigates sleep management's role in enhancing performance and recovery for ultramarathon runners, emphasizing strategies to counteract the negative effects of sleep deprivation.

14 Apr 2024

New natural supplement shows promise in preventing postpartum blues

A new study published in the Lancet discovery science journal eClinicalMedicine has confirmed that a novel natural supplement - invented, researched, developed and commercialized at the Centre for Addiction and Mental Health (CAMH) - prevents postpartum blues, and reduces symptoms of postpartum depression over the following six months after giving birth.

10 Apr 2024

Tryptophan digestion by gut microbiome spurs arthritis inflammation

A University of Colorado Department of Medicine faculty member says she and her colleagues have identified the means in which bacteria in the digestive system can break down tryptophan in the diet into an inflammatory chemical that primes the immune system towards arthritis.

7 Mar 2024

Innovative in-vehicle sensing system helps detect cognitive decline in older drivers

An estimated 4 to 8 million older adults with mild cognitive impairment are currently driving in the United States, and one-third of them will develop dementia within five years.

29 Feb 2024

Nearly one-third of adults struggle to meet recommended sleep duration, study reveals

It's official. Getting the recommended 7-9 hours of sleep a night is currently out of reach for almost one-third of the population as Flinders University experts found 31% of adults had average sleep durations outside the recommended range.

23 Feb 2024